PLoS ONE (Jan 2019)

Correction: Serum matrix metalloproteinase 3 levels are associated with an effect of iguratimod as add-on therapy to biological DMARDs in patients with rheumatoid arthritis.

  • Nao Tokai,
  • Shuzo Yoshida,
  • Takuya Kotani,
  • Ayaka Yoshikawa,
  • Yuko Kimura,
  • Youhei Fujiki,
  • Yoko Matsumura,
  • Tohru Takeuchi,
  • Shigeki Makino,
  • Shigeki Arawaka

DOI
https://doi.org/10.1371/journal.pone.0211750
Journal volume & issue
Vol. 14, no. 1
p. e0211750

Abstract

Read online

[This corrects the article DOI: 10.1371/journal.pone.0202601.].